Document is current

Article History

Received: 3 January 2026

Accepted: 11 May 2026

First Online: 29 June 2026

Declarations

:

: T. Takayama, Grants or contracts (Alcon); H. Takahashi, Grants or contracts (Kyowa Kirin, Novartis, Bayer, Linical), Consulting fees (Boehringer Ingelheim), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Kyowa Kirin, Santen, Bayer, Senju, Boehringer Ingelheim, Chugai, HOYA, Novartis, Nikon), Support for attending meetings and/or travel (Kyowa Kirin, Santen, Bayer, Senju, Boehringer Ingelheim, Chugai, HOYA, Novartis, Nikon), Patents planned, issued or pending (DeepEyeVision), Stock or stock options (DeepEyeVision); T. Tsuge, Employee (DeepEyeVision); M. Chiba, Employee (DeepEyeVision); M. Esmaeelpour, Employee (Boehringer Ingelheim); S. Inoda, Grants or contracts (HOYA, Chugai, Santen), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Kowa, Santen, Novartis, Bayer, Chugai, Astellas, Senju); H. Tampo, None ; Y. Hashimoto, None; K. Kimura, Employee (Boehringer Ingelheim); Y. Fukuju, Patents planned, issued or pending (DeepEyeVision), Stock or stock options (DeepEyeVision); T. Kaburaki, Grants or contracts (Eisai, Santen, AbbVie, Senju, Daiichi-Sankyo, Kowa, HOYA, Alcon), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, AbbVie, Novartis, Tanabe-Mitsubishi, Eisai, Kowa, Wakamoto, Senju, Otsuka, Ono, Daiichi-Sankyo, Chugai), Support for attending meetings and/or travel (Santen, AbbVie, Novartis, Tanabe-Mitsubishi, Eisai, Kowa, Wakamoto, Senju, Otsuka, Ono, Daiichi-Sankyo, Chugai); Y. Yanagi, None.